Showing results (31-40 of 660) with videos related to
Sort By:
Pageof 66
Trials|January 10, 2016
Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient surveySing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, et al.Therapeutic Advances in Medical Oncology|March 2, 2016
Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinomaNoelia Tarazona, Elizabeth C Smyth, Clare Peckit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and HopesIan ChauDiseases of the Colon and Rectum|September 10, 2011
Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?Jessica Evans, Diana Tait, Ian Swift, et al.The Oncologist|February 18, 2017
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer PatientsFrancesco Sclafani, Federica Morano, David Cunningham, et al.Hematology (Amsterdam, Netherlands)|April 25, 2007
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)Bhawna Sirohi, David Cunningham, Andy Norman, et al.Anticancer Research|October 3, 2018
Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary CentreAvani Athauda, David Watkins, Kabir Mohammed, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancerNaureen Starling, David Watkins, David Cunningham, et al.Clinical Colorectal Cancer|October 2, 2012
Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resectionAnastasia Constantinidou, David Cunningham, Fatima Shurmahi, et al.Expert Review of Gastroenterology & Hepatology|August 17, 2021
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinomaShubham Gupta, Sikandar Khan, Michal Kawka, et al.Pageof 66